4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-21-004183
VP, Corporate Controller sold 2,671 shares at an average $135.86 ($362,888)
- VP, Corporate Controller acquired 2,433 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Goldstein Dan · VP, Corporate Controller
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-04 | Exercise or conversion : show line 1 in the form | +1,457 | $34.21 | $49,844 | 3,206 | D |
| 2021-02-04 | Sale : show line 2 in the form | −1,457 | $135.84 | $197,919 | 1,749 | D |
| 2021-02-04 | Exercise or conversion : show line 3 in the form | +476 | $93.52 | $44,516 | 2,225 | D |
| 2021-02-04 | Sale : show line 4 in the form | −476 | $135.88 | $64,679 | 1,749 | D |
| 2021-02-04 | Exercise or conversion : show line 5 in the form | +500 | $98.03 | $49,013 | 2,249 | D |
| 2021-02-04 | Sale : show line 6 in the form | −500 | $135.72 | $67,860 | 1,749 | D |
| 2021-02-04 | Sale : show line 7 in the form | −238 | $136.26 | $32,430 | 1,511 | D |
| Open-market sales · 2,671 sh · avg $135.86 · $362,888 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-04 | Exercise or conversion : show line 8 in the form Non-qualified Stock Option (Right to Buy) | −1,457 | 0 | D |
| 2021-02-04 | Exercise or conversion : show line 9 in the form Non-qualified Stock Option (Right to Buy) | −476 | 952 | D |
| 2021-02-04 | Exercise or conversion : show line 10 in the form Non-qualified Stock Option (Right to Buy) | −500 | 1,503 | D |
Loading xslF345X03/form4.xml…